Seroatlas · Human Serome Atlas

CPT2

Carnitine O-palmitoyltransferase 2, mitochondrial

Also known as: CPT1, CPT2_HUMAN, CPTASE

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P23786
Gene
CPT2
Ensembl
ENSG00000157184
Chromosome
1
Canonical length
658 aa
Protein class
Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Nucleoli,Mitochondria

OverviewNCBI Gene

The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

658 residues, UniProt reviewed canonical sequence.

>P23786|CPT2
     1  MVPRLLLRAW PRGPAVGPGA PSRPLSAGSG PGQYLQRSIV PTMHYQDSLP RLPIPKLEDT
    61  IRRYLSAQKP LLNDGQFRKT EQFCKSFENG IGKELHEQLV ALDKQNKHTS YISGPWFDMY
   121  LSARDSVVLN FNPFMAFNPD PKSEYNDQLT RATNMTVSAI RFLKTLRAGL LEPEVFHLNP
   181  AKSDTITFKR LIRFVPSSLS WYGAYLVNAY PLDMSQYFRL FNSTRLPKPS RDELFTDDKA
   241  RHLLVLRKGN FYIFDVLDQD GNIVSPSEIQ AHLKYILSDS SPAPEFPLAY LTSENRDIWA
   301  ELRQKLMSSG NEESLRKVDS AVFCLCLDDF PIKDLVHLSH NMLHGDGTNR WFDKSFNLII
   361  AKDGSTAVHF EHSWGDGVAV LRFFNEVFKD STQTPAVTPQ SQPATTDSTV TVQKLNFELT
   421  DALKTGITAA KEKFDATMKT LTIDCVQFQR GGKEFLKKQK LSPDAVAQLA FQMAFLRQYG
   481  QTVATYESCS TAAFKHGRTE TIRPASVYTK RCSEAFVREP SRHSAGELQQ MMVECSKYHG
   541  QLTKEAAMGQ GFDRHLFALR HLAAAKGIIL PELYLDPAYG QINHNVLSTS TLSSPAVNLG
   601  GFAPVVSDGF GVGYAVHDNW IGCNVSSYPG RNAREFLQCV EKALEDMFDA LEGKSIKS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CPT2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.23
Highest tissue expression
85 nTPM

Expression across tissuesHPA

Tissue

  • liver: 85 nTPM
  • colon: 33 nTPM
  • kidney: 33 nTPM
  • tongue: 31 nTPM
  • rectum: 31 nTPM
  • duodenum: 31 nTPM

Single-cell type

  • cytotrophoblasts: 108 nCPM
  • hepatocytes: 102 nCPM
  • early primary spermatocytes: 71 nCPM
  • syncytiotrophoblasts: 69 nCPM
  • retinal pigment epithelial cells: 64 nCPM
  • colonocytes: 49 nCPM

Immune cell

  • non-classical monocyte: 21 nTPM
  • intermediate monocyte: 20 nTPM
  • myeloid DC: 18 nTPM
  • eosinophil: 15 nTPM
  • classical monocyte: 14 nTPM
  • naive CD4 T-cell: 11 nTPM

Brain region

  • choroid plexus: 33 nTPM
  • thalamus: 16 nTPM
  • white matter: 16 nTPM
  • medulla oblongata: 15 nTPM
  • basal ganglia: 14 nTPM
  • cerebellum: 14 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CPT2.

Disease | AllUniProt

Conditions CPT2 is implicated in, by any mechanism.

Disease | GeneticClinVar

226 pathogenic / likely-pathogenic of 1,151 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.17
gnomAD pLI
0
gnomAD missense Z
0.4
DepMap mean gene effect
-0.11
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of CPT2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CPT2 as an antibody target. Whether an autoantibody or antibody against CPT2 could matter depends on whether native CPT2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CPT2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CPT2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CPT2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...